Ok so neu has made it very clear that tox studies and commercialisation work needs to be done prior to p3 starting and I’d say u can pretty much guarantee that’s where r/d money is going
If they were going alone in p3, which I put at the same chance as lopez’s 6c CR (for a number of reasons) the ramp up costs in preparation for that would be much higher than 1.8 mill
Anyway u lot keep jumping at shadows it’s keeping me entertained while mgmt put a bow on this
Ann: Appendix 4C - quarterly, page-23
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.560(2.90%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $19.80 | $20.00 | $19.40 | $3.777M | 191.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1060 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.87 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |